9 results
Drugs Interacting with Sulfonylureas

Drugs that may reduce the effects of sulfonylureas, leading to loss of glucose
Drugs Interacting ... sulfonylureas, leading ... sulfonylureas, leading ... #Interactions # ... Pharmacology
Summary of characteristics of Platelet Aggregation Inhibitors

#AntiPlatelet #Inhibitors #Pharmacology #Table #Overview #Interactions #Pharmacology #Cardiology
AntiPlatelet #Inhibitors #Pharmacology ... #Table #Overview ... #Interactions # ... Pharmacology #Cardiology
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
AND DRUG INTERACTIONS ... #Medications #Cardiology ... #Pharmacology # ... Therapy #Table #Overview
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓)
of cytochrome p450 CYP3A4 and P-glycoprotein.

DOACs are substrates
(DOAC interactions ... DOACs thereby leading ... metabolization leading ... to have major interactions ... #Table #Pharmacology
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
 • Night-blooming
Cardiovascular Drug-Drug Interactions ... alpha-blockers, leading ... effects #DrugDrug #Interactions ... supplementals #herbal #pharmacology ... #DDI #table #cardiology
Digoxin Dosing - Pharmacology

Loading: 0.5 mg IV followed by 0.25 mg IV q6h x 2
Maintenance: 0.125
Digoxin Dosing - Pharmacology ... Loading: 0.5 mg ... Digoxin #Dosing #Pharmacology ... #loading #maintenance ... #cardiology
Hydroxychloroquine - Risks and Benefits in Lupus
Benefits:
↓ Disease activity, ↓ Flare, ↓ Damage, ↓ Corticosteroid dose,
nausea, diarrhea, bloating ... other medications leading ... very rare if no interaction ... Benefits #Lupus #pharmacology
Antiarrhythmics Pharmacology Summary
Cardiac Conduction Phases:
Phase 0 - Ventricular Depolarization:
 • Na+ channels open leading to a
Antiarrhythmics Pharmacology ... channels open leading ... channels open leading ... inotropy) ACCP Cardiology ... Antiarrhythmics #Pharmacology
Iron Deficiency in Congestive Heart Failure (CHF)

Iron deficiency (ID) in heart failure is a common comorbidity
50% of patients, leading ... #Failure #CHF #pharmacology ... pathophysiology #cardiology